In cases of endometrial cancer, Recio et al. (2024) performed ctDNA testing targeting TP53, ARID1A, and PIK3CA in 101 stage I patients, both at initial diagnosis and following surgical intervention [91]. Here, PIK3CA is linked to endometrial cancer.